The Engineering of Kidney Organoids Proceeds Apace
This is the organoid era of tissue engineering. Researchers are making earnest progress in establishing the recipes that allow cells to be grown into small, functional tissue sections. They lack a network of capillaries, however, so must be no more than a millimeter or so in thickness in order for nutrients to perfuse sufficiently through the tissue to support all of its cells. Every organ, every tissue has a significantly different recipe, but it is usually something that can be derived from an examination of the biochemistry of embryonic growth, with enough time and funding. Given the large number of different tissues ve...
Source: Fight Aging! - March 12, 2019 Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs
The Heart of The Matter: Technology In The Future of Cardiology
Sound, rhythm, rate, structure, function – countless features of the heart are measured to keep it healthy for as long as possible. Recently, an army of digital health technologies joined the forces of traditional preventive tools in cardiology to counter stroke, heart attack, heart failure or any other cardiovascular risks. In the future, minuscule sensors, digital twins, and artificial intelligence could strengthen their ranks. Let’s see what the future of cardiology might look like!
Fitness trackers, chatbots and A.I.
against heart disease
Let’s say 36-year-old Maria living in Sao Paulo in
2033 decides one d...
Source: The Medical Futurist - March 12, 2019 Category: Information Technology Authors: nora Tags: Artificial Intelligence in Medicine Future of Medicine Health Sensors & Trackers Portable Diagnostics cardiology cardiovascular cardiovascular diseases digital digital twin health trackers heart heart health heart rate heart soun Source Type: blogs
Blood Test for Early Stage Cancer Diagnosis: Interview with Dr. Van Etten, CMO of Laboratory for Advanced Medicine
The Laboratory for Advanced Medicine (LAM), a biotechnology company headquartered in the US, offers non-invasive, early stage cancer detection tests that will use the IvyGene Platform. These IvyGene tests are based on detecting genomic DNA shed by cancer cells into the blood stream. By assessing cell-free DNA found in blood samples, the company can measure the extent to which methyl groups are present in DNA at certain locations in order to detect the presence of cancer. Many cancers demonstrate very distinctive DNA methylation patterns, making this an effective way to detect a very small number of cancer cells in the body...
Source: Medgadget - March 4, 2019 Category: Medical Devices Authors: Conn Hastings Tags: Diagnostics Exclusive Oncology Pathology Source Type: blogs
Fight Aging! Newsletter, March 4th 2019
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more.
This content is...
Source: Fight Aging! - March 3, 2019 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
AI in Healthcare: Interview with Chris Gough, GM Health and Life Sciences, Intel Corporation
Intel has developed a suite of AI technologies and has been collaborating with numerous medtech providers to create new healthcare solutions based on data-driven strategies. AI has come on in leaps and bounds, and is beginning to make an impact in various healthcare fields. Intel aims to be at the forefront of this AI revolution.
For instance, Intel has collaborated with Novartis to perform high content drug screening. The company uses Intel neural network technology to analyze thousands of images of cells to identify promising drug candidates. Previously, technicians analyzed these images manually, which was tedious and ...
Source: Medgadget - February 27, 2019 Category: Medical Devices Authors: Conn Hastings Tags: Exclusive Informatics Medicine Public Health Source Type: blogs
